Common Movement Disorders Affecting the Larynx: A Report from the Neurolaryngology Committee of the AAO-HNS

1 Richardson BE Bastian RW. Clinical evaluation of vocal fold paralysis. Otolaryngol Clin North Am 2004;37:45–58.

2 Hillel AD Benninger M Blitzer R . Evaluation and management of bilateral vocal cord immobility. Otolaryngol Head Neck Surg 1999;121:760–5.

3 Blitzer A. Neurologic disorders of the larynx. New York: Thieme; 1992.

4 Carrau R Murry T. Comprehensive management of swallowing disorders. San Diego: Singular; 1998.

5 Ossoff RH. The larynx. New York: Lippincott, 2002.

6 Altman KW Simpson CB Amin MR . Cough and paradoxical vocal fold motion. Otolaryngol Head Neck Surg 2002;127:501–11.

7 Price CJ , The anatomy of language: contributions from functional neuroimaging, J Anat 2000; 197: 335–59.

8 Alcock KJ Wade D Anslow P , Pitch and timing abilities in adult left-hemisphere-dysphasic and right-hemisphere-damaged subjects. Brain Lang 2000; 75: 47–65.

9 Marien P Engelborghs S Fabbro F . The lateralized linguistic cerebellum: a review and a new hypothesis. Brain Lang 2001;79:580–600.

10 Rigueiro-Veloso MT Pego-Reigosa R Branas-Fernandez F . Wallenberg syndrome: a review of 25 cases. Rev Neurol 1997;25:1561–4.

11 Hendricks HT Van Limbeek J Geurts AC . Motor recovery after stroke: a systematic review of the literature. Arch Phys Med Rehab 2002;83:1629–37.

12 Hartmann E Von Cramon D. Acoustic measurement of voice quality in central dysphonia. J Commun Disord 1984;17:425–40.

13 Feigin VL Lawes CMM Bennett DA . Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the later 20th century. Lancet Neurol 2003;2:43–53.

14 Ramsey DJ Smithard DG Kalra L. Early assessment of dysphagia and aspiration risk in acute stroke patients. Stroke 2003;34:1252–7.

15 Hartelius L Svensson P. Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey. Folia Phoniatr Logop 1994;46:9–17.

16 Perez KS Ramig LO Smith ME . The Parkinson's larynx: tremor and videostroboscopic findings. J Voice 1996;10:354–61.

17 Luschei ES Ramig LO Baker KL . Discharge characteristics of laryngeal single motor units during phonation in younger and older adults and in persons with Parkinson's disease. J Neurophysiol 1999;81:2131–9.

18 Kim SH Kearney JJ Atkins JP. Percutaneous laryngeal augmentation for treatment of Parkinsonian hypophonia. Otolaryngol Head Neck Surg 2002;126:653–6.

19 Berke GS Gerratt B Kreiman J . Treatment of Parkinson's hypophonia with percutaneous collagen augmentation. Laryngoscope 1999;109:1295–9.

20 Gentil M Chauvin P Pinto S . Effect of bilateral stimulation of the subthalamic nucleus on Parkinsonian voice. Brain Lang 2001;78:233–40.

21 Sanabria J Ruiz PG Gutierrez R . The effect of levodopa on vocal function in Parkinson's disease. Clin Neuropharmacol 2002;24:99–102.

22 Kompoliti K Wang QE Goetz CG . Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology 2000;54:458–62.

23 Poluha PC Euling HL Brookshire RH. Handwriting and speech changes across the levodopa cycle in Parkinson's disease. Acta Psychol 1998;100:71–84.

24 Ramig LO Sapir S Countryman S . Intensive voice treatment (LSVT) for patients with Parkinson's disease: a two year follow up. J Neurol Neurosurg Psychiatry 2001;71:493–8.

25 Sharkawi AE Ramig LO Logemann JA . Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study. J Neurol Neurosurg Psychiatry 2002;72:31–6.

26 Liotti M Ramig LO Vogel D . Hypophonia in Parkinson's patients: neural correlates of voice treatment revealed by PET. Neurology 2003;60:432–40.

27 Factor SA Weiner WJ. Hyperkinetic movement disorders. In: Weiner WJ Goetz CG , eds. Neurology for the non-neurologist. Philadelphia, PA: Lippincott, Williams & Wilkins; 1999. p. 143–77.

28 Koller WC Busenbark K Miner K. The relationship of essential tremor to other movement disorders: report on 678 patients. Ann Neurol 1994;35:717–23.

29 Findley LJ Gresty M. Head, facial and voice tremor. Adv Neurol 1988;49:239–53.

30 Elble RJ. Diagnostic criteria for essential tremor and differential diagnosis. Neurology 2000;54(Suppl 4):S2–6.

31 Louis ED Ottman R. How familial is familial tremor The genetic epidemiology of essential tremor. Neurology 1996;46:1200–5.

32 Lou JS Jankovic J. Essential tremor: clinical correlates in 350 patients. Neurology 1991;41:234–8.

33 Louis ED Ford B Barnes LF. Clinical subtypes of essential tremor. Arch Neurol 2000;57:1194–8.

34 Louis ED Marder K Cote L . Prevalence of a history of shaking in persons 65 years of age or older: diagnostic and functional correlates. Mov Disord 1996a;11:63–9.

35 Elble RJ. Tremor in ostensibly normal elderly people. Mov Disord 1998;13:457–64.

36 Jankovic J. Essential tremor: clinical characteristics. Neurology 2000;54(Suppl 4):S21–5.

37 Fahn S Greene PE Ford B . Handbook of movement disorders. Philadelphia: Current Medicine, Inc; 1998.

38 Koller WC Hristova A Brin M. Pharmacologic treatment of essential tremor. Neurology 2000;54(Suppl 4):S30–8.

39 Tomoda H Shibasaki H Kuroda Y . Voice tremor: dysregulation of voluntary expiratory muscles. Neurology 1987;37:117–22.

40 Koda J Ludlow CL. An evaluation of laryngeal muscle activation in patients with voice tremor. Otolaryngol Head Neck Surg 1992;107:684–96.

41 Finnegan EM Luschei ES Barkmeier JM . Arch Otolaryngol Head Neck Surg 2003; 129: 313–8.

42 Mendoza E Carballo G. Vocal tremor and psychological stress. J Voice 1999;13:105–12.

43 Gamboa J Jimenez-Jimenez FJ Nieto A . Acoustic voice analysis in patients with essential tremor. J Voice 1998;12:444–52.

44 Perez KS Ramig LO Smith ME . The Parkinson larynx: tremor and videostroboscopic findings. J Voice 1996;10:354–61.

45 Aronson AE Hartman DE. Adductor spastic dysphonia as a sign of essential voice tremor. J Speech Hear Disord 1981;46:52–8.

46 Barkmeier JM Case JL Ludlow CL. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges. J Commun Disord 2001;34:21–37.

47 Blitzer A Brin MF Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 1998;108:1435–41.

48 Hartman DE Vishwanat B. Spastic dysphonia and essential (voice) tremor treated with primidone. Arch Otolaryngol 1984;110:394–7.

49 Koller WC Graner D Micoch A. Essential voice tremor: treatment with propranolol. Neurology 1985;35:106–8.

50 Muenter MD Daube JR Caviness JN . Treatment of essential tremor with methazolamide. Mayo Clin Proc 1991;66:991–7.

51 Busenbark K Ramig L Dromey C . Methazolamide for essential voice tremor. Neurology 1996;47:1331–2.

52 Warrick P Dromey C Irish JC . Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection. Laryngoscope 2000;110:1366–74.

53 Warrick P Dromey C Irish J . The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report. J Voice 2000;14:410–2.

54 Hertegard S Granqvist S Lindestad PA. Botulinum toxin injections for essential voice tremor. Ann Otol Rhinol Laryngol 2000;109:204–9.

55 Carpenter MA Pahwa R Miyawaki KL . Reduction in voice tremor under thalamic stimulation. Neurology 1998;50:796–8.

56 Yoon MS Munz M Sataloff RT . Vocal tremor reduction with deep brain stimulation. Stereotact Funct Neurosurg 1999;72:241–4.

57 Pahwa R Lyons K Koller WC. Surgical treatment of essential tremor. Neurology 2000; 54(Suppl 4): S39–44.

58 Taha JM Janszen MA Favre J. Thalamic deep brain stimulation for the treatment of head, voice and bilateral limb tremor. J Neurosurg 1999;91:68–72.

59 Scott AB. Botulinum toxin into extraocular muscles as an alternative to strabismus surgery. J Pediatr Ophthalmol Strabismus 1980; 17: 21–5.

60 Blitzer A Brin MF Fahn S Lange D Lovelace RE. Botulinum toxin (BOTOX) for the treatment of “spastic dysphonia” as part of a trial of toxin injections for the treatment of other cranial dystonias. Laryngoscope 1986;96:1300–1.

61 Blitzer A Brin MF Fahn S . Localized injections of botulinum toxin for the streatment of focal laryngeal dystonia (spastic dysphonia). Laryngoscope 1988;98:193–7.

62 Blitzer A Brin MF. Laryngeal dystonia: a series with botulinum toxin therapy. Ann Otol Rhinol Laryngol 1991;100:85–9.

63 Ludlow C L. Treatment of speech and voice disorders with botulinum toxin. JAMA 1990;264:2671–5.

64 Rosen M Malmgren LT Gacek RR. Three-dimensional computer reconstruction of the distribution of neuromuscular junctions in the thyroarytenoid muscle. Ann Otol Rhinol Laryngol 1983;92:424–9.

65 Langeveld TP Drost HA Baatenburg De Jong Rt. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 1998;107:280–4.

66 Bielamowicz S Ludlow CL. The effects of botulinum toxin on pathophysiology in adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 2000:109:194–203.

67 Maloney AP Morrison MD. A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia. J Otolaryngol 1994;23:160–4.

68 Adams SG Hunt EJ Charles DA . Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results. J Otolaryngol 1993;22:171–5.

69 Bielamowicz S Badillo A Stager S . Unilateral vs. bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia. J Voice 2002; 16: 117–23.

70 Murry T Woodson GE. Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy. J Voice 1995;9:460–5.

71 Dedo HH. Recurrent laryngeal nerve section for spastic dysphonia. Ann Otol Rhinol Laryngol 1976;85:451–9.

72 Dedo HH Behlau MS. Recurrent laryngeal nerve section for spastic dysphonia: 5- to 14-year preliminary results in the first 300 patients. Ann Otol Rhinol Laryngol 1991:100:274–9.

73 Aronson AE Desanto LW. Adductor spastic dysphonia: three years after recurrent laryngeal nerve resection. Laryngoscope 1983;93:1–8.

74 Sapir S Aronson AE Thomas JE. Judgment of voice improvement after recurrent laryngeal nerve section for spastic dysphonia: clinicians versus patients. Ann Otol Rhinol Laryngol 1986;95:137–41.

75 Netterville JL Stove RE Rainey C . Recurrent laryngeal nerve avulsion for treatment of spastic dysphonia. Ann Otol Rhinol Laryngol 1991;100:10–14.

76 Weed DT Jewett BS Rainey C . Long-term follow-up of recurrent laryngeal nerve avulsion for the treatment of spastic dysphonia. Ann Otol Rhinol Laryngol 1996;105:592–601.

77 Isshiki N Haji T Yamamoto Y . Thyroplasty for adductor spasmodic dysphonia: further experiences. Laryngoscope 2001;111:615–21.

78 Berke GS Blackwell KE Gerratt BR . Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 1999;108:227–31.